Gore & Associates announced FDA approval of an expanded indication for the company’s Viabahn VBX balloon expandable e ...

Sonorous Neurovascular announced that the FDA approved an investigational device exemption (IDE) authorizing the company to ...

One-year results from the prospective, multicenter, single-arm PROMISE III trial evaluated transcatheter arterialization of the ...

The ELEGANCE registry, which focuses on historically underrepresented populations to generate real-world evidence, evaluated en ...

A post hoc analysis of the randomized HI-PEITHO study examined potential predictors of major bleeding in patients with acute in ...

A study of computer-assisted vacuum thrombectomy (CAVT) met its predefined primary effectiveness and safety endpoints for the t ...

Six-month results from Esprit BTK PAS were reported in patients with chronic limb-threatening ischemia (CLTI) treated with the ...

Results from the prospective, single-arm, multicenter POWER PAD II study demonstrated that the Pulse intravascular lithotripsy ...

Stryker Peripheral Vascular announced that the American Medical Association (AMA) Current Procedural Terminology (CPT) ...

Cordis announced that its Selution SLR Sustane percutaneous transluminal angioplasty (PTA) sirolimus drug-eluting balloon ...

Endovascular Engineering, Inc. (E2), a developer of technology for venous thromboembolism, announced FDA 510(k) clearance for b ...

A secondary analysis of the randomized SirPAD trial demonstrated lower rates of target-lesion revascularization (TLR) and major ...